Stockscreener 앱 받기
0.6515
5.58%
-0.0385
시간 외 거래:
.65
-0.0015
-0.23%
전일 마감가:
$0.69
열려 있는:
$0.68
하루 거래량:
194.15K
Relative Volume:
0.06
시가총액:
$12.31M
수익:
$48.54M
순이익/손실:
$-36.23M
주가수익비율:
-0.2773
EPS:
-2.3494
순현금흐름:
$-9.60M
1주 성능:
-5.85%
1개월 성능:
-12.35%
6개월 성능:
-45.25%
1년 성능:
-1.29%
1일 변동 폭
$0.6401
$0.725
1주일 범위
$0.6401
$0.83
52주 변동 폭
$0.48
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Compare TRIB vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.6515 | 13.04M | 48.54M | -36.23M | -9.60M | -2.3494 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-10-23 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2015-09-03 | 개시 | Raymond James | Outperform |
| 2015-07-29 | 재확인 | ROTH Capital | Buy |
| 2008-07-22 | 재확인 | Roth Capital | Buy |
| 2008-03-17 | 재확인 | Roth Capital | Buy |
| 2007-12-10 | 재확인 | Roth Capital | Buy |
| 2007-10-26 | 재확인 | Roth Capital | Buy |
모두보기
Trinity Biotech Plc Adr 주식(TRIB)의 최신 뉴스
Trinity Biotech advances CGM+ device toward pivotal trial - Investing.com
Trinity Biotech secures $25M equity financing facility - Investing.com
Trinity Biotech secures $25M equity financing facility By Investing.com - Investing.com South Africa
Trinity Biotech receives Nasdaq delisting warning notice - Investing.com
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares - GlobeNewswire Inc.
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com India
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification By Investing.com - Investing.com South Africa
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech plc (TRIB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Trinity Biotech plc's (NASDAQ:TRIB) Share Price Boosted 54% But Its Business Prospects Need A Lift Too - Sahm
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Benzinga
TRIB: Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty - TradingView — Track All Markets
TRIB: Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss - TradingView — Track All Markets
Trinity Biotech secures $5 million funding, extends credit agreement - Investing.com India
Trinity Biotech stock soars after major HIV test order signals market recovery By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech secures $5 million funding, extends credit agreement By Investing.com - Investing.com South Africa
Trinity Biotech receives 9 million unit order for HIV screening product - Investing.com
Trinity Biotech receives 9 million unit order for HIV screening product By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system - Investing.com
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system By Investing.com - Investing.com South Africa
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech plc (TRIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trinity Biotech receives WHO approval for outsourced HIV test manufacturing - Investing.com
Trinity Biotech (TRIB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $TRIB - MarketBeat
Why You Need Trinity Biotech Plc ADR (TRIB) On Your Watchlist - fostersleader.com
Operating cash flow per share of Trinity Biotech Plc Sponsored ADR Class A – LS:A404JF - TradingView
EBIT per share of Trinity Biotech plc ADR – MUN:TRB0 - TradingView
Top investors say Banco Macro S.A. ADR (BMA) ticks everything they need - Setenews
Trinity Biotech : 2025 AGM Notice Sent to holders of Ordinary Shares - MarketScreener
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com
Trinity Biotech reports positive results for calibration-free CGM - Investing.com
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
India Hba1c Testing Devices Market Size & Outlook, 2024-2030 - Grand View Research
Saudi Arabia Lyme Disease Testing Market Size & Outlook, 2030 - Grand View Research
India Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Indonesia Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
UK Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
Trinity Biotech names new Chief Commercial Officer By Investing.com - Investing.com UK
Trinity Biotech appoints new biosensor marketing director - Investing.com
Trinity Biotech Plc Adr (TRIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):